Strattera, the brand name for atomoxetine, was first approved by the U.S. Food and Drug Administration (FDA) for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adults in November 2002. It was the first non-stimulant medication approved for ADHD. The drug became available on the market shortly thereafter.
Copyright © 2026 eLLeNow.com All Rights Reserved.